Autoimmune Diseases  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

25 Trials

   Remove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Autoimmune Diseases
NCT00862758: Request for Single Patient IND for Compassionate/Emergency Use of Tocilizumab

No Longer Available
N/A
US
Tocilizumab
University of Oklahoma, Hoffmann-La Roche
Juvenile Idiopathic Arthritis
10/10
10/10
LBRA99, NCT00931086: Expanded Access Trial of Belimumab Antibody in RA Patients Who Were Previously Treated Under HGS Protocol

No Longer Available
N/A
US
belimumab, BENLYSTA™ (belimumab), LymphoStat-B™
Human Genome Sciences Inc., a GSK Company, GlaxoSmithKline
Rheumatoid Arthritis
12/11
12/11
NCT01373333: Use Of 3,4-Diaminopyridine (3,4-DAP) In The Treatment Of Lambert Eaton Myasthenic Syndrome

No Longer Available
N/A
US
3,4 DAP
The Cleveland Clinic
Lambert-Eaton Myasthenic Syndrome
09/12
 
NCT02441920: Chronic Periodontitis and Tooth Loss in Patients With Rheumatoid Arthritis

Terminated
N/A
400
NA
University of Birmingham, Dudley Group NHS Foundation Trust
Periodontitis, Rheumatoid Arthritis
11/12
11/12
NCT00948493: Treatment Use of Generex Oral-lyn™ in Patients With Diabetes

No Longer Available
N/A
US
Buccal insulin spray, Generex Oral-lynTM (oral, buccal insulin spray)
Generex Biotechnology Corp.
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
 
 
NCT01049633: B-Lymphocyte Immunotherapy in Islet Transplantation for Initial Islet Graft Failure

No Longer Available
N/A
US
Allogeneic Pancreatic Islet Cells, Sirolimus, Basiliximab, Tacrolimus, Antibacterial, Antifungal, and Antiviral Prophylaxis, Trimethoprim/sulfamethoxazole, Septra SS, Clotrimazole, Mycelex Troche, Valganciclovir, Valcyte, Heparin, Anticoagulation and Hematological Agent, Enoxaparin, Lovenox; Anticoagulation and Hematological Agent, Pentoxifylline, Aspirin, ASA
National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type 1 Diabetes Mellitus
 
 
NCT01378546: Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) With 3, 4 DAP

No Longer Available
N/A
US
3,4-diaminopyridine
Louis H. Weimer, MD
Lambert Eaton Myasthenic Syndrome (LEMS)
05/15
 
NCT02008188: Early Feasibility Study of Adaptive Advisory/Automated (AAA) Control of Type 1 Diabetes (Italy)

Active, not recruiting
N/A
12
Europe
Closed Loop Control with the Advisory/Automated Adaptive (AAA) Control system
University of Virginia, National Institutes of Health (NIH)
Type 1 Diabetes Mellitus
05/15
05/15
NCT02264405: Autologous SCT for Progressive Systemic Sclerosis: a Prospective NIS Study

Recruiting
N/A
50
Europe
Autologous HSCT
European Group for Blood and Marrow Transplantation
Autoimmune Diseases
12/15
12/17
NCT01309022: Immunosuppressive Medications for Participants in ITN005CT (NCT00014911)

No Longer Available
N/A
US
Sirolimus, Rapamune®, Tacrolimus, Prograf®, Mycophenolate mofetil, MMF, CellCept, Mycophenolic acid, Myfortic®
National Institute of Allergy and Infectious Diseases (NIAID), Immune Tolerance Network (ITN)
Diabetes Mellitus, Type 1
 
 
NCT01789151: 99m-Technetium- Glucosamine in Arthritis

No Longer Available
N/A
RoW
Technetium labelled glucosamine
University of Sydney, AbbVie
Rheumatoid Arthritis, Ankylosing Spondylitis
 
 
NCT02149732: Clinical Trial on the Effect of Autologous Oral Mucosal Epithelial Sheet Transplantation

Available
N/A
RoW
cultivated oral mucosal epithelial sheet transplantation
Seoul National University Hospital, Ministry of Health & Welfare, Korea
Limbal Stem Cell Deficiency, Stevens-johnson Syndrome, Ocular Cicatricial Pemphigoid, Chemical Burn
12/16
12/16
NCT02807285: Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis

No Longer Available
N/A
US
Ocrelizumab, RO4964913
Genentech, Inc.
Multiple Sclerosis
 
 
NCT03125486: Compassionate Use for Subcutaneous (SC) Belimumab

No Longer Available
N/A
US
SC belimumab 200 mg
GlaxoSmithKline
Systemic Lupus Erythematosus
 
 
NCT02722070: Processing Integration in Neurological Patients Using fMRI

Not yet recruiting
N/A
150
RoW
3 Tesla Siemens Skyra MRI scanner
Hadassah Medical Organization
Acute Inflammatory Demyelinating Polyradiculoneuropathy, Stroke, Anosognosia, Central and Peripheral Neurodegenerative Pathologies, Neuropsychiatric Conditions
03/20
03/25
NCT02557295: An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With RA

Terminated
N/A
248
NA
Celltrion
Rheumatoid Arthritis
03/20
03/20
NCT03006991: Study of Methotrexate Given to Juvenile Idiopathic Arthritis Patients Based on Pharmacogenomics and Pharmacometrics

Recruiting
N/A
100
RoW
therapeutic drug monitoring
Guangzhou Women and Children's Medical Center
Juvenile Idiopathic Arthritis
12/20
12/23
JAQI, NCT02684695: Juvenile Arthritis Quantitative Imaging

Recruiting
N/A
200
Europe
MRI scan (adolescent spine protocol), MRI scan (whole body protocol)
University College London Hospitals
Arthritis, Juvenile Idiopathic, Enthesitis-Related Arthritis, Juvenile
01/21
01/26
PreCARA, NCT01345071: Preconceptional Counselling in Active Rheumatoid Arthritis

Recruiting
N/A
150
Europe
J.M.W. Hazes, Erasmus Medical Center, Dutch Arthritis Association
Rheumatoid Arthritis, Pregnancy
06/21
05/25
NCT02210741: Next-generation Sequencing (NGS) of Peripheral Blood Immune Repertoire in Graves' Disease

Not yet recruiting
N/A
200
RoW
National Taiwan University Hospital
Graves Disease
02/24
02/24
ART, NCT03062865: French National Registry: REGISTRY (Observational Study)

Recruiting
N/A
1500
Europe
No intervention
Assistance Publique - Hôpitaux de Paris, Societe Francaise de Rhumatologie
RheumatoId Arthritis
11/24
02/25
NCT01055093: Prospective Study on Diabetes Mellitus and Its Complications in Newly Diagnosed Adult Patients

Recruiting
N/A
2000
Europe
German Diabetes Center
Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
09/25
09/35
NCT02889016: Neurobiologic, Immunologic, and Rheumatologic Markers in Youth With PANS

Recruiting
N/A
500
US
Stanford University
Pediatric Acute-Onset Neuropsychiatric Syndrome, Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections, PANS, PANDAS
03/28
03/28
NCT01088360: Safety Study of Abatacept to Treat Rheumatoid Arthritis (B)

Active, not recruiting
N/A
20000
NA
Bristol-Myers Squibb, National Data Bank for Rheumatic Diseases (NDB)
Rheumatoid Arthritis
06/29
06/29
RelSEP, NCT02883335: Lorraine Registry of Multiple Sclerosis

Recruiting
N/A
6000
Europe
Observational registry
Central Hospital, Nancy, France, Institut National de la Santé Et de la Recherche Médicale, France, University of Lorraine
Multiple Sclerosis
01/30
01/30

Download Options